Zanic-Grubisić T, Zrinski R, Cepelak I, Petrik J, Radić B, Pepeljnjak S
Department of Medical Biochemistry and Hematology, University of Zagreb, Zagreb, 10000, Croatia.
Toxicol Appl Pharmacol. 2000 Sep 1;167(2):132-9. doi: 10.1006/taap.2000.8987.
Ochratoxin A (OTA) is a nephrotoxic, hepatotoxic, and teratogenic mycotoxin produced by storage molds on a variety of foodstuffs. Its chemical structure is composed of an isocumarin part linked to l-phenylalanine. Inhibition of phenylalanine hydroxylase and other enzymes that use phenylalanine as substrate is based on this structural homology. We have examined the effects of low doses of ochratoxin A on the activity of phenylalanine hydroxylase in kidney and in liver of experimental animals. Daily administration of ochratoxin A (50 microg/kg body wt, for 10 and 35 days, respectively) caused a significant reduction in the phenylalanine hydroxylase activity. Inhibition was more pronounced in liver than in kidney, although actual ochratoxin A concentration was higher in the kidney tissue. We observed an apparent increase in the affinity of phenylalanine hydroxylase for substrate following OTA administration to animals. However, simple competitive inhibition was observed for both tissues in vitro (K(i liver) = 0.0119 +/- 0.002 mM and K(i kidney) = 0.13 +/- 0.026 mM). Simultaneous application of ochratoxin A with phenylalanine could reduce inhibition of phenylalanine hydroxylase, in particular in liver. Enzyme activity was almost completely preserved after 35 days of combined treatment. The results obtained suggest that daily administration of ochratoxin A in low doses produced an inhibitory effect that could be diminished by competitive action of l-phenylalanine.
赭曲霉毒素A(OTA)是一种由多种食品上的贮藏霉菌产生的具有肾毒性、肝毒性和致畸性的霉菌毒素。其化学结构由与L-苯丙氨酸相连的异香豆素部分组成。基于这种结构同源性,苯丙氨酸羟化酶和其他以苯丙氨酸为底物的酶受到抑制。我们研究了低剂量赭曲霉毒素A对实验动物肾脏和肝脏中苯丙氨酸羟化酶活性的影响。每天分别给予赭曲霉毒素A(50微克/千克体重,持续10天和35天)导致苯丙氨酸羟化酶活性显著降低。尽管肾脏组织中实际的赭曲霉毒素A浓度较高,但肝脏中的抑制作用比肾脏中更明显。我们观察到给动物施用OTA后,苯丙氨酸羟化酶对底物的亲和力明显增加。然而,在体外对两种组织均观察到简单的竞争性抑制(肝脏的K(i) = 0.0119 +/- 0.002毫摩尔,肾脏的K(i) = 0.13 +/- 0.026毫摩尔)。同时将赭曲霉毒素A与苯丙氨酸一起施用可以减少对苯丙氨酸羟化酶的抑制,尤其是在肝脏中。联合治疗35天后酶活性几乎完全得以保留。所获得的结果表明,每天低剂量施用赭曲霉毒素A会产生抑制作用,而L-苯丙氨酸的竞争性作用可以减弱这种抑制作用。